Welcure Drugs & Pharmaceuticals Ltd to Approve Q3 Results on Feb 12, 2026

Welcure Drugs & Pharmaceuticals Ltd has announced that its Board of Directors will meet on February 12, 2026, to consider and approve the un-audited financial results for the quarter and nine months ended December 31, 2025. The meeting will be held at the company's registered office in New Delhi, India. The trading window for dealing in the securities of the company for all designated persons, designated employees, specified persons, and their immediate relatives was closed from January 01, 2026, till the expiry of 48 hours after the declaration of the unaudited standalone financial results for the quarter and nine months ended on December 31, 2025.